课题基金 / 基金详情

Langerhans Cells and Nerves: Bidirectional Signaling

Langerhans Cells and Nerves: Bidirectional Signaling
朗格汉斯细胞和神经:双向信号传导
批准号:
6918410
负责人:
RICHARD David GRANSTEIN
金额:
$36.96万
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-02-01 至 2010-05-31

项目摘要

项目成果

RICHARD David GRANSTEIN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): There is substantial evidence that stress, emotional status and neural activity modulate immunological responsiveness. However, except for endocrine effects, the mechanism(s) of this regulation remain obscure at the cellular and molecular levels. One system that is amenable to establishing mechanistic links is the cutaneous immune system. In the skin, Langerhans cells (LCs), antigen presenting cells in the epidermis, are innervated. Furthermore, our laboratory has previously established that norepinephrine (NE), epinephrine (EPI) and three neuropeptides [calcitonin gene-related peptide (CGRP), pituitary adenylate activating polypeptide (PACAP), and vasoactive intestinal peptide (VIP)] are all able to modulate cutaneous immune responses in vivo and in vitro. This neuro-immunological interaction is probably important in (a) some pathological conditions (atopic dermatitis, psoriasis, autoimmune disorders), (b) the normal responses to invading pathogens and (c) the response to antigens during vaccination. Nevertheless, there are substantial gaps in understanding these pathways. It is not known which intracellular signaling pathway(s) are responsible for mediating the effects of neurotransmitters or if different neurotransmitters influence different pathways. Although nerves influence Th1 responses, it is not clear if they influence Th2 responses or the balance of Th1 to Th2 responses. We propose herein to test the hypothesis that neurotransmitters modulate both Th1- and Th2-dependent immune responses by modulating intracellular signaling pathways, especially the cAMP-dependent inhibition of NFkappaB activation. A correlate of this hypothesis is that the nervous system may have a role in selecting the type of immune response that occurs. This will be done in 3 specific aims: Aim 1 - To identify and study the intracellular signaling events that mediate the effects of NE/EPI, PACAP, VIP, and CGRP on the maturation of LCs. Aim 2 - To determine if neuro-peptides or neurotransmitters modulate the Th2 response, the Th1/Th2 cytokine balance and/or antibody production. Aim 3 - To determine if denervation influences the number of LCs, their maturation state or their capacity to induce contact hypersen-sitivity. By further exploring the types of cutaneous immune responses that are regulated by the nervous system and by determining the molecular mechanisms of this regulation, we will create the knowledge needed for rational design of drugs to modify cutaneous immune responses in pathological and normal. Immune responses in the skin.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neurotransmitter Regulation of Immunity Through Effects on Endothelial Cells
  • 批准号:
    8702657
  • 项目类别:
  • 资助金额:
    $22.37万
  • 财政年份:
    2014
  • 负责人:
    RICHARD David GRANSTEIN
  • 依托单位:
Neurotransmitter Regulation of Immunity Through Effects on Endothelial Cells
  • 批准号:
    8826027
  • 项目类别:
  • 资助金额:
    $18.65万
  • 财政年份:
    2014
  • 负责人:
    RICHARD David GRANSTEIN
  • 依托单位:
Vaccine Development: Purinergic Agonists as Adjuvants
  • 批准号:
    6754602
  • 项目类别:
  • 资助金额:
    $33.6万
  • 财政年份:
    2004
  • 负责人:
    RICHARD David GRANSTEIN
  • 依托单位:
Vaccine Development: Purinergic Agonists as Adjuvants
  • 批准号:
    6891607
  • 项目类别:
  • 资助金额:
    $33.6万
  • 财政年份:
    2004
  • 负责人:
    RICHARD David GRANSTEIN
  • 依托单位:
国内基金
海外基金
全细胞疫苗Cell@MnO2的乳腺癌术后免疫响应监测与放射免疫治疗研究
  • 批准号:
    QN25H220002
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    顾媛
  • 依托单位:
染色体外环状DNA以cell-in-cell途径促进基因横向传递和扩增的研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    15.0万元
  • 批准年份:
    2024
  • 负责人:
    王锐智
  • 依托单位:
GMFG/F-actin/cell adhesion 轴驱动 EHT 在造 血干细胞生成中的作用及机制研究
  • 批准号:
    TGY24H080011
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    李鸿鹄
  • 依托单位:
基于In-cell NMR策略对“舟楫之剂”桔梗中引经药效物质的快速发现研究
  • 批准号:
    82305053
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    王丽明
  • 依托单位: